BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18991480)

  • 1. Systematic analysis of outcomes evaluations applied to drug management programs.
    McAdam-Marx C; Schaaf DT; Holtorf AP; Eng B; Oderda GM
    Am J Manag Care; 2008 Nov; 14(11 Suppl):SP36-45. PubMed ID: 18991480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demand management: another marketing tool or a way to quality care?
    Mohler MJ; Harris JM
    J Eval Clin Pract; 1998 May; 4(2):103-11. PubMed ID: 9839636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach.
    Mather DB; Sullivan SD; Augenstein D; Fullerton DS; Atherly D
    Am J Manag Care; 1999 Mar; 5(3):277-85. PubMed ID: 10351024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of administrative-only versus administrative plus chart review data for reporting HEDIS hybrid measures.
    Pawlson LG; Scholle SH; Powers A
    Am J Manag Care; 2007 Oct; 13(10):553-8. PubMed ID: 17927459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician evaluations of care management practices in Medicaid programs.
    Avery GH; Wholey DR; Christianson JB
    Am J Manag Care; 2005 Mar; 11(3):156-64. PubMed ID: 15786854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug utilization review in the managed care environment.
    Briesacher B; DuChane J
    Med Interface; 1995 Mar; 8(3):72-4, 76-8. PubMed ID: 10141391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
    Giraldes Mdo R
    Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of ambulatory care measures: a review of clinical and financial impact from an employer/payer perspective.
    de Brantes F; Wickland PS; Williams JP
    Am J Manag Care; 2008 Jun; 14(6):360-8. PubMed ID: 18554074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health outcomes analysis and its applications].
    Carrera-Hueso FJ
    Rev Med Univ Navarra; 1997; 41(4):237-44. PubMed ID: 10420964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving optimal maternal and infant health outcomes for Medicaid patients, with application for commercial populations.
    Foust RF; Carey B
    Manag Care Interface; 2002 Jun; 15(6):45-50, 53-4. PubMed ID: 12087607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of chronic disease management on outcomes and cost of care for Medicaid beneficiaries.
    Zhang NJ; Wan TT; Rossiter LF; Murawski MM; Patel UB
    Health Policy; 2008 May; 86(2-3):345-54. PubMed ID: 18207282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond health plans: behavioral health disorders and quality of diabetes and asthma care for Medicaid beneficiaries.
    Clark RE; Weir S; Ouellette RA; Zhang J; Baxter JD
    Med Care; 2009 May; 47(5):545-52. PubMed ID: 19319000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does disease management work?
    Pasternak DP; Harris JM
    Physician Exec; 1996 Dec; 22(12):28-32. PubMed ID: 10163279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of claims data provides extra punch for disease management efforts.
    Healthc Demand Dis Manag; 1998 Dec; 4(12):189-91. PubMed ID: 10339126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug utilization review: mechanisms to improve its effectiveness and broaden its scope. The U.S. Pharmacopeia Drug Utilization Review Advisory Panel.
    J Am Pharm Assoc (Wash); 2000; 40(4):538-45. PubMed ID: 10932464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are outcomes and care processes for preterm neonates influenced by health insurance status?
    Brandon GD; Adeniyi-Jones S; Kirkby S; Webb D; Culhane JF; Greenspan JS
    Pediatrics; 2009 Jul; 124(1):122-7. PubMed ID: 19564291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.
    Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT;
    Pharmacotherapy; 2009 Jan; 29(1):128. PubMed ID: 19113803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstrate effectiveness of your CM program.
    Hosp Case Manag; 1999 Jun; 7(6):100-1. PubMed ID: 10557711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality monitoring and management in commercial health plans.
    Landon BE; Rosenthal MB; Normand SL; Frank RG; Epstein AM
    Am J Manag Care; 2008 Jun; 14(6):377-86. PubMed ID: 18554076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.